ReviewFrontiers in cardiovascular medicine2021

MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review.

Liuying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.